INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member

LA JOLLA, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient?s innate immune system to fight disease, is pleased to announce that Edgardo (Ed) Baracchini, Ph.D., has joined the company?s board of directors.